Daniel Low

Daniel Low is currently an advisor at TAE Life Sciences. Daniel has over twenty years of experience in the field of pharmacology and has worked for several major pharmaceutical companies.

Low began their career as a research technician at the University of Puerto Rico in 1992. Daniel then joined Cadus Pharmaceutical Corp. as an associate research scientist in 1996. In 1999, they began working for the Kenneth S. Warren Institute as a research associate.

In 2002, Low joined Agensys Inc./Astellas Pharma U.S. as a senior principal associate in the pharmacology department. Daniel held this position for sixteen years, during which time they were promoted to senior research associate II and then senior research associate I. In 2018, they left Astellas to join Xencor as an associate scientist.

Low has made significant contributions to the field of pharmacology during their career. Daniel has published numerous papers in scientific journals and has been involved in the development of several new drugs. Daniel is highly respected by their peers and is considered an expert in their field.

Daniel Low received their MS in Biology from Universidad de Puerto Rico and their BS in Biology from Universidad de Puerto Rico.